__timestamp | ACADIA Pharmaceuticals Inc. | Iovance Biotherapeutics, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 32748000 | 9335772 |
Thursday, January 1, 2015 | 90804000 | 12390000 |
Friday, January 1, 2016 | 186456000 | 25602000 |
Sunday, January 1, 2017 | 255062000 | 21262000 |
Monday, January 1, 2018 | 265758000 | 28430000 |
Tuesday, January 1, 2019 | 325638000 | 40849000 |
Wednesday, January 1, 2020 | 388661000 | 60210000 |
Friday, January 1, 2021 | 396028000 | 83664000 |
Saturday, January 1, 2022 | 369090000 | 104097000 |
Sunday, January 1, 2023 | 402466000 | 106916000 |
Data in motion
In the competitive world of biotechnology, managing operational costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of ACADIA Pharmaceuticals Inc. and Iovance Biotherapeutics, Inc. from 2014 to 2023. Over this period, ACADIA consistently outspent Iovance, with its SG&A expenses peaking at approximately $402 million in 2023, a 23% increase from 2014. In contrast, Iovance's expenses grew more modestly, reaching around $107 million in 2023, marking a significant 104% increase from its 2014 figures. This disparity highlights ACADIA's aggressive investment in administrative and sales functions, potentially reflecting a broader strategy to capture market share. Meanwhile, Iovance's more conservative spending may indicate a focus on lean operations. Understanding these trends provides valuable insights into each company's strategic priorities and financial health.
Breaking Down SG&A Expenses: AstraZeneca PLC vs Iovance Biotherapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Insmed Incorporated and Iovance Biotherapeutics, Inc.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Iovance Biotherapeutics, Inc.
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or Iovance Biotherapeutics, Inc.
Who Optimizes SG&A Costs Better? ACADIA Pharmaceuticals Inc. or MannKind Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
Iovance Biotherapeutics, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?